By Pharmadule Morimatsu…
To get in touch with Pharmadule Morimatsu to exhibit at ISPE Biotechnology Europe in Dublin, simply fill out the form below.
Subscribe to Supplier
Pharmadule Morimatsu to exhibit at ISPE Biotechnology Europe in Dublin
Nacka, Stockholm: – Pharmadule Morimatsu AB (Pharmadule), the Swedish-based specialist in facility engineering, will exhibit at the ISPE 2017 Europe Biotechnology Conference in Dublin later this month.
Pharmadule will also be an exhibitor at the conference on September 26-27. The Pharmadule team will showcase their expertise in advanced design and construction, gathered over more than 30 years in engineering modular facilities and process equipment solutions around the world.
“We will be showing visitors to our stand in Dublin how we can offer solutions that are faster, lower risk, more predictable, of consistent high quality, fixed in price but flexible in operation,” said Leo Fällgren, Director of Business Development for Pharmadule Morimatsu.
The Pharmadule team will also have information on the company’s turnkey design and construction services, modular off-site production solutions, commissioning and qualification expertise, GMP consultancy and extended after-sales services.
“As one of the world-leading companies in supplying modular production facilities for the pharma and biotech industry, it is very important for us to be present at ISPE conferences,” commented Mr. Fällgren.
“The International Society for Pharmaceutical Engineering does fantastic work in promoting knowledge-sharing and networking in our industry and we enjoy being present at their meetings,” he added.
About Pharmadule Morimatsu
Pharmadule Morimatsu designs and builds turnkey production facilities and process equipment’s for the pharma – biopharma Industries and also for the FMCG area (Fast Moving Consumer Goods). Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.
The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.
Since then, Pharmadule has successfully delivered more than 70 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pfizer, AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.
Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, which specializes in process equipment, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.
About ISPE Europe Biotechnology Conference 2017
The International Society for Pharmaceutical Engineering organises a series of conferences worldwide, of which the ISPE Europe Conference on Biotechnology focuses on process science and technological advancements and trends to approach future manufacturing challenges in the biotechnology industry.
The 2017 conference is a two-day event, opening September 26 at the Crown Plaza Conference in Northwood Park, Dublin. The conference will explore a number of themes including Biotechnology Factories of the Future, Megatrends in Technology and Regulatory Development, and capacity constraints in Biologics.
Keynote speaker Gerald Kierans, from Pfizer, will address the capacity situation of CMOs, CROs, and Analytical Laboratories, while Dominic Carolan from NIBRT in Dublin will address the need for a qualified work force.
The conference also features a co-located exhibition.
The event is organised by ISPE with more information at: https://www.ispe.org/conferences/2017-europe-biotechnology